This post was written by Angel Smith Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors. Amidst a race with its ...
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...
"Lilly's next generation subcutaneous obesity treatment seems to be future proofing the company's weight management franchise," argued SA analyst BioCGT Investor. BioCGT expects the company to ...
2monon MSN
Eli Lilly (NYSE:LLY) is scheduled to announce Q3 ... LLY is up 55.6% so far this year and is rated as Hold according to SA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback